Sort
21,453 grants matching “tuberculosis”
Autophagy Against Tuberculosis and HIV
$658,214Vojo P Deretic · University Of New Mexico Health Scis Ctr · R01 · FY2017 · AI
SCH: INT: Collaborative Research: Smart Intervention Strategies for Hepatitis C Elimination
$658,058Jagpreet Chhatwal · Massachusetts General Hospital · · FY2017 · CSE
M. tuberculosis exosome detection for pediatric TB diagnosis
$658,038Sylvia Lacourse · University Of Washington · R01 · FY2024 · AI
Integrative Pharmacology Approach to Understand Mechanisms of TB Drug Resistance
$657,921Eric L Nuermberger · Johns Hopkins University · R01 · FY2015 · AI
Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Ototoxicity in Patients Receiving Intravenous Amikacin for Treatment of Non-Tuberculous Mycobacterium Infection
$657,906Kevin Loring Winthrop · Oregon Health & Science University · U01 · FY2022 · DC
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
$657,831Scott K Heysell · University Of Virginia · U01 · FY2022 · AI
Diagnostics and Pharmacotherapy for Severe Forms of TB
$657,815Scott K Heysell · University Of Virginia · U01 · FY2017 · AI
Role of IL-17 Cytokine Networks in TB Relapse Due to HIV
$657,714Janice J Endsley · University Of Texas Med Br Galveston · R01 · FY2020 · AI
Autophagy Against Tuberculosis and HIV
$657,490Vojo P Deretic · University Of New Mexico Health Scis Ctr · R01 · FY2016 · AI
CRDF GLOBAL WILL PROVIDE FIDUCIARY SUPPORT TO CDC TO MANAGE TB-RELATED ACTIVITIES
$657,070Shawn Trenton Wheeler · U S Civilian Research/ Development Fdn · U01 · FY2013 · PS
Molecular mechanisms of host cell escape by Mycobacterium tuberculosis
$656,965Volker Briken · Univ Of Maryland, College Park · R01 · FY2020 · AI
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB
$656,929Jyothi Rengarajan · Emory University · R01 · FY2018 · AI
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
$656,887Frederick Lewis Altice · Yale University · R01 · FY2018 · DA
Adapting and evaluating a brief advice tobacco intervention in high-reach, low-resource settings in India
$656,791Kasisomayajula Viswanath · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Investigating bacterial contributions to TB treatment response: a focus on in-host pathogen dynamics
$656,764Maha Farhat · Harvard Medical School · R01 · FY2021 · AI
Lung immune function in human TB infection and its perturbation by HIV-1.
$656,738David G Russell · Cornell University · R01 · FY2023 · AI
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis
$656,517Jennifer A Philips · Washington University · R01 · FY2023 · AI
Development of an automated HIV self-testing assay
$656,450Waseem Asghar · Florida Atlantic University · R33 · FY2025 · AI
Pathogenesis of oral microbes triggered by the cyclic deformation of biomaterials
$656,315Santiago Orrego · Temple Univ Of The Commonwealth · R56 · FY2024 · DE
TB Vaccine Development in Nonhuman Primate Model
$656,291John L Vandeberg · Texas Biomedical Research Institute · R01 · FY2009 · AI
Diagnostics and Pharmacotherapy for Severe Forms of TB
$656,184Scott K Heysell · University Of Virginia · U01 · FY2018 · AI
Autophagy Against Tuberculosis and HIV
$656,042Vojo P Deretic · University Of New Mexico Health Scis Ctr · R01 · FY2015 · AI
Autophagy Against Tuberculosis and HIV
$656,042Vojo P Deretic · University Of New Mexico Health Scis Ctr · R01 · FY2014 · AI
Chemical genetics of M. tuberculosis DosRST signaling and persistence
$655,967Robert B Abramovitch · Michigan State University · R01 · FY2023 · AI
Ag-specific gamma delta T cells and immunity to TB/AIDS-related TB
$655,890Zheng W Chen · University Of Illinois At Chicago · R01 · FY2017 · OD